In recent developments, the US Senate is set to vote on funding cuts proposed by the Trump administration, which initially threatened the Global AIDS program known as PEPFAR. However, the White House has agreed to exempt PEPFAR from these cuts, alleviating concerns over an impending AIDS funding crisis. Various stakeholders, including senators and humanitarian organizations, have voiced their opposition to deeper cuts in foreign aid, emphasizing the importance of PEPFAR in saving millions of lives. Despite this, debates continue regarding the accountability of the PEPFAR industry and the potential economic fallout from the overarching foreign aid cuts.